News
Eli Lilly, Novo Nordisk
Digest more
Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main ...
INDIANAPOLIS — Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from ...
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results